60 results
6-K
EX-10.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Current report (foreign)
5:28pm
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(n)RESERVED.
(o)Material
424B5
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
22 Jan 24
Prospectus supplement for primary offering
5:27pm
of Noncompliance requirement (Rule 5625), the Voting Rights requirement (Rule 5640) and that we have an audit committee that satisfies Rule 5605(c)(3 … and the Ministry of Finance of the PRC and, as summarized in the “Statement on Agreement Governing Inspections and Investigations of Audit Firms Based
6-K
EX-99.1
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
20 Dec 23
Current report (foreign)
4:06pm
and audit
Auditors
Record dates
Dividends
Source of dividends
Declaration of dividends by Members
Payment of interim dividends and declaration of final … shall establish an audit committee, a compensation committee and a nominating and corporate governance committee. Each of these committees shall
424B3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
20 Dec 23
Prospectus supplement
4:03pm
on Agreement Governing Inspections and Investigations of Audit Firms Based in China and Hong Kong” published on the U.S. Securities and Exchange Commission’s … or take testimony from all personnel of the audit firms whose issuer engagements are being inspected or investigated; (iii) the PCAOB shall have
F-3
EX-23.2
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
5 Dec 23
Shelf registration (foreign)
4:06pm
with respect to our audit of the consolidated statement of financial position of March 31, 2023, and consolidated statements of profit and loss and other
F-3
pd4laju
5 Dec 23
Shelf registration (foreign)
4:06pm
F-3
EX-23.1
gcjapwjo9prflkjvehg
5 Dec 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.1
gyi5h
8 Nov 23
Current report (foreign)
4:11pm
6-K
EX-99.4
zntnt9 9wtohlkfdp40
8 Nov 23
Current report (foreign)
4:11pm
6-K
mb94e9km1w6b
21 Apr 23
Current report (foreign)
4:30pm
424B3
016ftv
31 Mar 23
Prospectus supplement
4:04pm
424B3
4fmre9cwml0z
2 Dec 22
Prospectus supplement
4:17pm
F-1
era et9x2
18 Nov 22
Registration statement (foreign)
5:39pm
6-K
EX-10.1
39csriofbmepn4
18 Nov 22
Current report (foreign)
5:20pm
6-K
EX-10.3
vzasi0i r04
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
6-K
EX-10.1
1dptl9 gii
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
20-F
EX-12.1
lgs6jag
12 Aug 22
Annual report (foreign)
4:20pm